Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.
腎移植接受者中的他汀類藥物使用、全因死亡率及與維持免疫抑制劑的相互作用。
J Am Soc Nephrol 2024-02-01
Low skeletal muscle mass index is independently associated with low bone mineral density in kidney transplant recipients: a retrospective observational cohort study.
腎移植接受者中低骨骼肌肉質量指數獨立與低骨密度相關:一項回顧性觀察性cohort研究。
J Nephrol 2024-04-17
Efficacy and Safety of Anti-Osteoporotic Agents Across CKD Stages: A Meta-Analysis of Randomized Clinical Trials.
慢性腎臟病各階段抗骨質疏鬆藥物的療效和安全性:隨機臨床試驗的荟萃分析。
Kidney Blood Press Res 2024-07-07
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action.
慢性腎病患者與一般人群的椎骨骨折:呼籲診斷與行動。
Clin Kidney J 2024-08-05
Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients.
Denosumab 在腎臟移植受者中治療骨質疏鬆的有效性與安全性。
Kidney Res Clin Pract 2024-12-05
Denosumab 在改善腎臟移植受者(KTRs)骨質疏鬆的骨礦物質密度(BMD)方面顯示出潛力,儘管臨床效果仍有爭議。研究顯示,接受治療一年後,股骨頸和脊椎的 T 分數顯著提升。雖然有三起新骨折和心血管事件,且部分患者出現低鈣血症,但整體來看,denosumab 對 KTRs 的骨質疏鬆治療是有效且安全的,建議密切監測尿路感染等併發症。
PubMedDOI
Clinical Significance of Incident Osteoporotic Fractures After Kidney Transplantation: A National Korean Cohort Study.
腎臟移植後骨質疏鬆性骨折的臨床意義:一項全國性韓國隊列研究。
Am J Kidney Dis 2024-12-14